{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "NOK", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -1.3442891, "regularMarketPrice": 26.42, "exchange": "OSL", "shortName": "NYKODE THERAPEUTICS ASA", "longName": "Nykode Therapeutics AS", "messageBoardId": "finmb_61534042", "exchangeTimezoneName": "Europe/Oslo", "market": "no_market", "regularMarketTime": 1684140706, "regularMarketDayHigh": 26.9, "regularMarketDayRange": "25.68 - 26.9", "regularMarketDayLow": 25.68, "regularMarketVolume": 56631, "regularMarketPreviousClose": 26.78, "bid": 26.32, "ask": 26.42, "fullExchangeName": "Oslo", "financialCurrency": "USD", "regularMarketOpen": 26.9, "averageDailyVolume3Month": 626209, "averageDailyVolume10Day": 397114, "fiftyTwoWeekLowChange": 6.24, "fiftyTwoWeekLowChangePercent": 0.30921704, "fiftyTwoWeekRange": "20.18 - 39.44", "fiftyTwoWeekHighChange": -13.019999, "fiftyTwoWeekHighChangePercent": -0.33012167, "fiftyTwoWeekLow": 20.18, "fiftyTwoWeekHigh": 39.44, "earningsTimestamp": 1677596400, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.52, "epsForward": -1.15, "epsCurrentYear": -0.88, "priceEpsCurrentYear": -30.022728, "sharesOutstanding": 295494016, "bookValue": 0.533, "fiftyDayAverage": 24.4624, "fiftyDayAverageChange": 1.9575996, "fiftyDayAverageChangePercent": 0.08002484, "twoHundredDayAverage": 28.3826, "twoHundredDayAverageChange": -1.9626007, "twoHundredDayAverageChangePercent": -0.06914802, "marketCap": 7831601664, "forwardPE": -22.973913, "priceToBook": 49.56848, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1602054000000, "priceHint": 2, "regularMarketChange": -0.3600006, "symbol": "NYKD.OL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Oslo Research Park", "address2": "Gaustadalleen 21", "city": "Oslo", "zip": "0349", "country": "Norway", "phone": "47 22 95 81 93", "website": "https://nykode.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for COVID-19 T cell vaccine development; and research agreement with Regeneron. The company was formerly known as Vaccibody AS. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.", "fullTimeEmployees": 149, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael Thyring Engsig", "age": 50, "title": "Chief Exec. Officer", "yearBorn": 1972, "fiscalYear": 2021, "totalPay": {"raw": 567000, "fmt": "567k", "longFmt": "567,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Agnete B. Fredriksen Ph.D.", "age": 45, "title": "Pres, Chief Bus. Officer & Co-founder", "yearBorn": 1977, "fiscalYear": 2021, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Harald  Gurvin", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2021, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mikkel Wandahl Pedersen Ph.D.", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2021, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Louise  Stubbe", "title": "Chief Legal Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter  Fatum", "title": "VP & Head of Quality", "fiscalYear": 2021, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Klaus  Edvardsen M.D., Ph.D.", "age": 60, "title": "Chief Devel. Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}